Petros Pharmaceuticals In...

0.07
-0.01 (-16.67%)
At close: Apr 02, 2025, 3:59 PM
0.07
-2.91%
After-hours: Apr 02, 2025, 07:57 PM EDT

Petros Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Revenue 5.11B 5.82M 5.99M 7.81M 9.56M 15.58M 14.05M
Cost of Revenue 1.21B 1.63M 2.29M 1.6M 4.05M 7.43M 10.48M
Gross Profit 3.9B 4.19M 3.7M 6.21M 5.51M 8.15M 3.57M
Operating Income -17.68B -13.62M -15.85M -18.05M -17.28M -16.87M -7.65M
Interest Income 371.77M 515.31K 14.19K 368.66K 3.05M 13.84M 11.86M
Pretax Income -14.32B -8.16M -20.04M -8.99M -22.01M -33.16M -32.49M
Net Income -26.8B -8.16M -27.04M -9.36M -20.59M -32.51M -32.47M
Selling & General & Admin 8.75B 9.26M 12.21M 15.59M 15.67M 19.73M 11.22M
Research & Development 2.62B 2.41M 1.74M 1.79M 459.64K n/a n/a
Other Expenses 9B 6.14M 5.6M 6.88M 6.66M 5.29M n/a
Operating Expenses 20.37B 17.81M 19.55M 24.26M 22.8M 25.02M 11.22M
Interest Expense -560.91M 536.14K 596.02K 368.66K 3.05M 13.84M n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a -41.15K
Cost & Expenses 21.58B 19.44M 21.84M 25.86M 26.84M 32.45M 21.7M
Income Tax 12.48B n/a 7M 368.66K -1.43M -645.87K -13.37K
Shares Outstanding (Basic) 80.26M 2.18M 2.07M 1.09M 970.76K 170.7K 100K
Shares Outstanding (Diluted) 80.26M 2.18M 2.07M 1.09M 970.76K 170.7K 100K
EPS (Basic) -333.88 -6.35 -13.06 -8.59 -21.21 -190.46 -324.73
EPS (Diluted) -333.88 -6.35 -13.06 -8.59 -21.21 -190.46 -324.73
EBITDA -12.05B -4.21M -13.73M -1.64M -12.21M -14M 373.58K
EBIT -14.88B -7.63M -19.44M -8.62M -18.96M -19.31M -20.63M
Depreciation & Amortization 2.83B 3.42M 5.72M 6.98M 6.75M 5.32M 8.06M